An infection with linezolid-resistant S. aureus in a patient with left ventricular assist system.
We report an infection with a linezolid-resistant S. aureus in a patient with a left ventricular assist system. Linezolid should be used with caution when invasive devices or foreign materials are in place or therapeutic courses last longer than 14 d. Previous cases of linezolid-resistant S. aureus are summarized.
Kola
Axel
A
Institute of Medical Microbiology and Hospital Epidemiology, Hannover, Germany. kola.axel@mh-hannover.de
Kirschner
Philip
P
Gohrbandt
Bernhard
B
Chaberny
Iris F
IF
Mattner
Frauke
F
Strüber
Martin
M
Gastmeier
Petra
P
Suerbaum
Sebastian
S
D000081:Acetamides / Q000494:pharmacology*; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D024901:Drug Resistance, Multiple, Bacterial; D005858:Germany; D006353:Heart-Assist Devices / Q000382:microbiology*; D006801:Humans; D000069349:Linezolid; D008297:Male; D008712:Methicillin; D008875:Middle Aged; D023303:Oxazolidinones / Q000494:pharmacology*; D016459:Prosthesis-Related Infections / Q000382:microbiology*; D013203:Staphylococcal Infections / Q000188:drug therapy* / Q000209:etiology; D013211:Staphylococcus aureus / Q000187:drug effects
D000081:Acetamides; D000900:Anti-Bacterial Agents; D023303:Oxazolidinones; D000069349:Linezolid; D008712:Methicillin